Jones Financial Companies Lllp Novo Cure LTD Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
A detailed history of Jones Financial Companies Lllp transactions in Novo Cure LTD stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,604 shares of NVCR stock, worth $28,807. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,604
Previous 441
263.72%
Holding current value
$28,807
Previous $13,000
115.38%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
265Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$218 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$202 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$161 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$99.2 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$93.7 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.88B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...